Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 160.03 billion as of February 21, 2025. Its market cap has decreased by -16.65% in one year.

Market Cap

160.03B

Enterprise Value

206.03B

Revenue

68.03B

Ranking

n/a

PE Ratio

n/a

Stock Price

810.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 160.03B, an increase of 4,931.62%. That is a compound annual growth rate of 14.39%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	160.03B	22.36%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	82.35T
Celltrion	37.80T
Yuhan	9,163.93B
SK Biopharmaceuticals	9,013.86B
SK bioscience	3,748.92B
Hanmi Pharm.	3,404.64B
Peptron	2,152.68B
Hanall Biopharma	1,985.31B

Market Cap Rankings